Established in 1973 and headquartered in Mumbai, India, Alkem began operations as a health care marketing company. Alkem has since grown to become India’s seventh largest pharmaceutical company with sales revenues exceeding USD 500 million with a CAGR of 16% over the last five years. With a wide ranging presence across acute and chronic therapeutic segments with substantial brand share in the Cent
ral Nervous System, Gastro-intestinal, Anti-diabetic, Anti-osteoporosis, Anti-malarial, Cardiovascular, Immunosuppressants, and Nutraceutical segments, Alkem leads the Indian market in the Anti-infective and Pain Management segments. Alkem’s portfolio of 800 brands in India, with 14 of the brands featured among the top 300 brands in India, is reflective of its strong brand recognition and marketing expertise. Alkem’s 7 world-class manufacturing facilities are compliant with the standards of global regulatory authorities including the US FDA, UK MHRA, MCC. Alkem, through its international operations team, markets branded and non-branded generic drugs in 48 countries globally.
